London, Canada and Tucson, Ariz., U.S. (September 29, 2021) – Critical Path Institute (C-Path) and Pulse Infoframe announced today their... read more →
Breaking Down Silos to Accelerate Research for Rare Kidney Disease London, Canada; Scottsdale, United States (September 7, 2021)—Alport Syndrome Foundation... read more →
August 12, 2021, London, Canada—PIP-UK is joining Rare Central, the rare disease platform powered by Pulse Infoframe, to create the... read more →
London, Canada; Rhode Island, United States (June 24, 2021) - QualityMetric and Pulse Infoframe announced today their partnership and vision... read more →
Pulse Infoframe & Quinten Health Partner to Advance Precision Medicine Through Real-World Evidence Generation London, Canada; Paris, France (March 23,... read more →
Supporting third-party data ingestion, embedded analytics, and consented data access to life sciences, providers, and advocacy organizations London, Canada (March 1, 2021) — Pulse Infoframe Inc.,... read more →
Launching a rare disease patient registry often requires patient advocacy groups to design a registry themselves or pay for an... read more →
July 20, 2020 — Robert Iannone, Executive Vice President, Research and Development and Chief Medical Officer at Jazz Pharmaceuticals Narcolepsy... read more →
Melbourne, Australia, July 20, 2020: It is estimated half the Australian population will experience a mental health disorder during their... read more →
London, Ontario, April 15, 2020: The impact of the pandemic on the mental health of the global population is unclear.... read more →
